The latest developments on Ebola, hepatitis B, long Covid - Summary - MDSpire

The latest developments on Ebola, hepatitis B, long Covid

  • By

  • Theresa Gaffney

  • May 28, 2026

  • 0 min

Share

Objective:

To summarize recent developments in the research and management of Ebola, hepatitis B, and long COVID.

Key Findings:
  • Uganda's border closure contradicts WHO recommendations.
  • 1 in 6 COVID-19 patients may develop long COVID.
  • 20% of hepatitis B patients achieved a functional cure in trials.
  • Engineered heart muscle patches show promise for heart recovery.
  • Liberty HealthShare has lowered costs for its members.
  • The U.S. health care system ranks poorly compared to other countries.
Interpretation:

Limitations:
  • The Ebola outbreak lacks specific medications or vaccines.
  • The hepatitis B cure rate is still considered low.
  • The heart patch study involved a small sample size.
Conclusion:

Original Source(s)

The latest developments on Ebola, hepatitis B, long Covid

  • by Theresa Gaffney

  • May 28, 2026

Related Content

Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination

Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.

Post-acute metabolic changes and risk of new-onset diabetes following COVID-19: a systematic review and meta-analysis

Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19: Mixed Methods Retrospective Cross-Sectional Study